Inactive Instrument

Natco Pharma Ltd. Stock NSE India S.E.

Equities

INE987B01018

Pharmaceuticals

End-of-day quote NSE India S.E.
- INR - Intraday chart for Natco Pharma Ltd.
Sales 2024 * 39.01B 468M Sales 2025 * 44.43B 533M Capitalization 179B 2.15B
Net income 2024 * 13.21B 158M Net income 2025 * 15.18B 182M EV / Sales 2024 * 4.59 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 4.03 x
P/E ratio 2024 *
13.6 x
P/E ratio 2025 *
11.8 x
Employees -
Yield 2024 *
1.04%
Yield 2025 *
1.17%
Free-Float 46.76%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 46 00-07-02
Founder 78 81-09-18
Director of Finance/CFO - -
Members of the board TitleAgeSince
Founder 78 81-09-18
Chief Executive Officer 46 00-07-02
Director/Board Member 70 14-04-17
More insiders
Natco Pharma Limited is an India-based vertically integrated, research and development (R&D)-focused pharmaceutical company. The Company is engaged in the business of pharmaceuticals, which comprises research and development, manufacturing and selling of bulk drugs and finished dosage formulations. The Company deals in the production of finished dosage formulations (FDF), which it sells in India, the United States and the Rest of the World, as well as active pharmaceutical ingredients (APIs). Its capabilities include multi-step synthesis, semi-synthetic fusion technologies, production of high-potency APIs and peptides. The Company operates through two segments: pharmaceuticals and agrochemicals. The pharmaceuticals segment, the Company drives its sales through FDFs and APIs. The agrochemicals segment is focused on niche products, including pest management.
More about the company